Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years

NCT04821310 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
43
Enrollment
INDUSTRY
Sponsor class

Stopped Pfizer has made an internal business decision to terminate the B1791094 study. This decision was not due to safety concerns or requests from any regulatory authorities.

Conditions

Interventions

Sponsor

Pfizer